IntraCoronary Bone Marrow Mononuclear Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IntraCoronary Bone Marrow Mononuclear Cells, covering 2020-03-17 to 2020-03-17. Get the full timeline:
Most recent: Clinical Trial Update: ICMNC-HF. IntraCoronary Bone Marrow MonoNuclear Cells in Heart Failure (HF) Patients [Phase 1, Phase 2]